fb-pixel tracker
News

Caris Life Sciences Further Bolsters Scientific Advisory Board With Four New Members

Industry thought leaders join a distinguished group of experts to advance Caris’ mission to expand the role of precision medicine in cancer care   IRVING, Texas, October 15, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today the addition of four members to its Scientific … Continued

Caris Life Sciences to Present New Research Across Tumor Types at ESMO Congress 2019

Presentations include findings on biomarkers in rare, untreatable form of testicular cancer, and analysis of differential responses to BRAF inhibitors in melanoma and colorectal cancers   IRVING, Texas, September 19, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that it will present … Continued

Caris Life Sciences to Present at Canaccord Genuity Annual Growth Conference

IRVING, Texas, July 31, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that Brian J. Brille, Vice Chairman of the Company, will present at the Canaccord Genuity’s 38th Annual Growth Conference on Wednesday, August 7, 2019, at 10 a.m. Eastern time. The … Continued

University of Puerto Rico Joins Caris Life Sciences’ Precision Oncology Alliance

Puerto Rico’s primary healthcare and medical research institution becomes the 28th member of Caris’ collaborative network dedicated to making cancer treatment more precise and effective.   IRVING, Texas, July 23, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that the University of … Continued

Caris Featured in Newsweek Cover Story

Caris Life Sciences is featured in the latest Newsweek feature/cover story. The article provides an overview of the current state of precision oncology (growing interest and abilities, but underutilized), addresses challenges (doctors lacking expertise in the area and expense/reimbursement issues, clinical trial enrollment for new drugs) and also highlights opportunities – with a keen focus … Continued

Caris Life Sciences Appoints Steven D. Averbuch, M.D., to Its Scientific Advisory Board

Averbuch, recently retired Vice President and Head of Precision Medicine at Bristol-Myers Squibb, brings more than 35 years of oncology drug and companion diagnostic development experience to Caris’ Scientific Advisory Board IRVING, Texas, July 03, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced … Continued

Caris Life Sciences’ Precision Oncology Alliance Publishes New Review of Molecular Testing in Cancer

Paper by collaborative network of clinicians and researchers examines the evolution of molecular profiling for metastatic solid tumors, providing a comprehensive overview of the state of precision oncology today  IRVING, Texas, June 6, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on precision medicine, today announced the publication of a seminal paper … Continued

Caris Life Sciences to Present at Jefferies 2019 Healthcare Conference

IRVING, Texas, June 4, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that Brian J. Brille, Vice Chairman of the Company, will present at the Jefferies 2019 Healthcare Conference on Friday, June 7, 2019, at 8:30 a.m. Eastern time. The conference is … Continued

1 2 3 20

About Our News

Search to find the latest new about Caris Molecular Intelligence®, sign up for news alerts, and be sure to follow us on social media.